BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7663294)

  • 1. [The action of the alkanol ammonium salts of aroxyacetic acids on the thrombocyte aggregation process].
    Kazimirovskaia VB; Semenova NV; Moskvitina LT; Nepsha VD; Novikova NV; Voronkov MG
    Eksp Klin Farmakol; 1995; 58(3):37-40. PubMed ID: 7663294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of lipid peroxidation-modified lipoproteins on thrombocyte aggregation].
    Azizova OA; Vlasova II
    Biull Eksp Biol Med; 1993 Nov; 116(11):485-7. PubMed ID: 8312535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of two synthetic glycoprotein IIb/IIIa antagonists, Ro 43-8857 and L-700,462, on platelet aggregation and bleeding in guinea-pigs and dogs: evidence that Ro 43-8857 is orally active.
    Cook NS; Bruttger O; Pally C; Hagenbach A
    Thromb Haemost; 1993 Nov; 70(5):838-47. PubMed ID: 8128443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipid peroxidation and thrombocyte aggregation in vibration disease].
    Aksenova VM; Gogoleva OI
    Gig Tr Prof Zabol; 1992; (2):25-7. PubMed ID: 1427296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of thiofedrine on platelet aggregation, intraplatelet cyclic cAMP and malondialdehyde in rats.
    Qu YZ; Li XX
    Methods Find Exp Clin Pharmacol; 1994 May; 16(4):253-6. PubMed ID: 8051984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tris-(2-hydroxyethyl)ammonium 2-methyl- and 2-methyl-4-chlorophenoxyacetate serve as effective inhibitors of thrombocyte aggregation and antioxidants.
    Mirskova AN; Adamovich SN; Mirskov RG; Voronkov MG
    Dokl Biol Sci; 2010; 433():244-6. PubMed ID: 20711867
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of platelet aggregation by diterpene acids from Pinus massoniana resin.
    Cheung HT; Fu SL; Smal MA
    Arzneimittelforschung; 1994 Jan; 44(1):17-25. PubMed ID: 8135873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antioxidative action of fibrinogen and the implications of this effect on platelet aggregation.
    Olinescu R; Niţă S; Popovici D; Hertoghe J
    Rom J Intern Med; 1994; 32(3):185-93. PubMed ID: 7866335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The antiaggregant activity of the synthetic antioxidant emoxipin].
    Stoliarov VA; Repin AN; Markov VA
    Eksp Klin Farmakol; 1993; 56(2):35-6. PubMed ID: 8348036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A role of lipid peroxidation in postoperative impairments of thrombocytic hemostasis in patients with lung cancer].
    Afanas'eva AN; Udut VV; Evtushenko VA
    Klin Med (Mosk); 2004; 82(8):37-9. PubMed ID: 15468723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, platelet anti-aggregating activity and anti-inflammatory activity of a series of beta-aminoxypropionic acids.
    Macchia M; Orlandini E; Rossello A; Bertini S; Soldani G; Baldacci M; Gervasi G
    Farmaco; 1994 Dec; 49(12):767-73. PubMed ID: 7893333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of tetrahydroberberine on platelet aggregation and thrombosis.
    Xuan B; Wang W; Li DX
    Zhongguo Yao Li Xue Bao; 1994 Mar; 15(2):133-5. PubMed ID: 8010106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation.
    Cook JJ; Sitko GR; Holahan MA; Stranieri MT; Glass JD; Askew BC; McIntyre CJ; Claremon DA; Baldwin JJ; Hartman GD; Gould RJ; Lynch JJ
    J Pharmacol Exp Ther; 1997 May; 281(2):677-89. PubMed ID: 9152373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the effects of cisplatin and cisplatinum (II)phosphonate complex on ADP-induced platelet aggregation in vitro.
    Kostka B; Ochocki J
    Pharmazie; 1996 Dec; 51(12):990-2. PubMed ID: 8985988
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effects of starfish sterol on platelet aggregation].
    Xu D; Xu S
    Zhong Yao Cai; 2000 Oct; 23(10):627-30. PubMed ID: 12575041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
    Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
    J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective conjugated fatty acids inhibit guinea pig platelet aggregation.
    Li G; Butz D; Dong B; Park Y; Pariza MW; Cook ME
    Eur J Pharmacol; 2006 Sep; 545(2-3):93-9. PubMed ID: 16890934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of new synthetic prostanoids on the aggregation activity of human thrombocytes].
    Petrukhina GN; Makarova VA; FReĭmanis IaF; Lozha EV
    Eksp Klin Farmakol; 1995; 58(6):45-8. PubMed ID: 8704613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins.
    Di Braccio M; Grossi G; Roma G; Grazia Signorello M; Leoncini G
    Eur J Med Chem; 2004 May; 39(5):397-409. PubMed ID: 15110966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of 11-deoxymisoprostol ethyl ether sodium salt on thrombocyte aggregation and prothrombin time].
    Gabdrakhmanova SF; Makara NS; Sapozhnikova TV; Baschenko NZh; Nazarov VS; Zarudiĭ FS
    Eksp Klin Farmakol; 2008; 71(2):40-2. PubMed ID: 18488906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.